Patents by Inventor Frederic Eeckman

Frederic Eeckman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200085754
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: July 12, 2019
    Publication date: March 19, 2020
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Publication number: 20190142759
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 16, 2019
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Patent number: 8435564
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: May 7, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara
  • Publication number: 20110274762
    Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
    Type: Application
    Filed: November 17, 2009
    Publication date: November 10, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Publication number: 20110091547
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: May 28, 2009
    Publication date: April 21, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara, Domenico Fanara